Ingredient intelligence

Palmitoyl pentapeptide-4

Peptide · Palmitoyl Pentapeptide-4 · C46H83N9O11

Palmitoyl pentapeptide-4 is a lipidated fragment of the type I collagen propeptide sequence, studied as a matrix-signalling peptide.

Molecular identity

Two-dimensional chemical structure of Palmitoyl pentapeptide-4
Formula
C46H83N9O11
Molecular weight
962.2 g/mol
PubChem CID
9862091
ChEBI
Data unavailable
Open PubChem record →

Biological targets

  • Collagen type I alpha 1 chain (COL1A1)

    low confidence

    associated with · structural protein

    UniProt P02452
  • Fibronectin 1 (FN1)

    low confidence

    associated with · structural protein

    UniProt P02751

Molecules & genes

Molecules

  • Pal-KTTKSC46H83N9O11 · 962.2 g/mol

Genes / proteins

How could this ingredient interact with biology?

Biological network

Ingredient → molecule → target → gene/protein → pathway → process → studied outcome. Relationship strength is drawn from the curated confidence tier; nothing is added to make the chain look complete.

100%
Palmitoyl pentapeptide-4Pal-KTTKS

drag to pan · hover to isolate a path · click a node for detail

IngredientMoleculeTargetGenePathwayProcessOutcome

7 lower-confidence relationships are hidden at this filter level. Use “Show more biology” to include them.

Text alternative for this network
  • Palmitoyl pentapeptide-4 is molecule Pal-KTTKShigh confidence

Biological pathways

Collagen biosynthesis and modifying enzymes

low confidence

Proposed feedback signalling on procollagen synthesis.

Reactome R-HSA-1650814

Evidence engine

Limited

Mostly mechanistic, animal or single-study evidence.

Skinceptor Evidence Index

44

experimental · of 100

This index is a research-navigation aid describing how much evidence exists and how it was produced. It is not a medical safety score, an efficacy guarantee, or a clinical recommendation.

Study composition

  • Randomised controlled trial1
  • In-vitro1
Total studies
2
Human studies
1
Largest sample
62
Range
2005–2013

Index breakdown

  • Study design quality57% × 28%

    Mean design weight across curated studies (meta-analysis 1.0, RCT 0.9, other human 0.7, review 0.45, animal 0.35, in-vitro 0.25).

  • Human evidence share33% × 22%

    Proportion of curated evidence measured in people rather than cells or animals.

  • Evidence volume50% × 14%

    Log-scaled count of curated studies, so volume alone cannot dominate the score.

  • Largest sample size60% × 12%

    Log-scaled largest reported sample size across curated human studies.

  • Replication33% × 12%

    Independent human studies, capped at three; one study is never treated as replicated.

  • Recency35% × 7%

    Linear decay over a twenty-year window from the most recent curated publication.

  • Source traceability0% × 5%

    Share of curated studies with a verified PMID or DOI in this dataset.

How is this determined? →

Insufficient comparable evidence for quantitative synthesis.

Research timeline

How the evidence accumulated

  1. 2005

    Palmitoyl pentapeptide and procollagen synthesis in fibroblast culture

    In-vitrosample size unavailable · International Journal of Cosmetic Science

  2. 2013

    A randomised trial of a pentapeptide-containing moisturiser for periorbital wrinkles

    Randomised controlled trialn = 62 · Journal of Cosmetic Dermatology

Ingredient fingerprint

9 nodes · 9 relationships · seed "palmitoyl-pentapeptide-4"

The fingerprint is a deterministic visual signature: ridge amplitude comes from the number of entities in each tier, node placement from identifier hashes, and opacity from confidence. Two ingredients can never produce the same figure unless their networks are identical.

Open in Biology as Art →

Research

2 curated studies

Randomised controlled trialJournal of Cosmetic Dermatology · 2013n = 62

A randomised trial of a pentapeptide-containing moisturiser for periorbital wrinkles

Reported small improvements in wrinkle depth versus vehicle, with overlapping confidence intervals on several endpoints.

LimitationsSmall effect size; identifier not verified; peptide not isolated from other actives in the formulation.

In-vitroInternational Journal of Cosmetic Science · 2005

Palmitoyl pentapeptide and procollagen synthesis in fibroblast culture

Reported increased collagen I and fibronectin expression in treated fibroblast cultures.

LimitationsIn-vitro; identifier not verified; no dermal delivery data.

Community evidence

Submitted by readers

Submit a study

Reader submissions appear here only after review. They are not part of the curated dataset and do not affect the Skinceptor Evidence Index.

No approved community submissions yet.

Sources